US/UK/Canada

Share

Contacts

  • Orexo
    Box 303 751 05 Uppsala
    +46 (0)18 780 88 00
    +46 (0)18 780 88 88
    http://www.orexo.com

    • Quotes

    With the acquisition of the rights to two digital health products from GAIA and the appointment of Dennis, a thought leader in the digital health industry in the US, we are well positioned to lead this development within the complementary disease areas of our pharmaceutical business.
    Nikolaj Sørensen, President and CEO
    Our strategy is to focus on solutions with scientifically proven therapeutic effect which will benefit the healthcare system as a whole and more importantly patients.
    Nikolaj Sørensen, CEO, about Digital Therapies
    I am convinced that DTx will become an integral and natural part of addiction treatment in the future. This digital therapy for OUD patients is perfectly positioned with Orexo’s competences and commercial organization in the US.
    Nikolaj Sørensen, President and CEO
    Mundipharma Australia has been a good partner in the approval process and we are confident that their experience and infrastructure will create a strong foundation for a successful launch of Zubsolv®
    Nikolaj Sørensen, President and CEO
    Pick a time period -
    Tags ( Active)

    Orexo appoints Nomination Committee and publishes financial calendar 2018/2019

    Uppsala, Sweden – October 8, 2018 – Prior to the Annual General Meeting 2019, Orexo appoints a Nomination Committee which represents approximately 45 percent of the number of shares and votes in the company based on the last known shareholder information. The Nomination Committee, whose tasks include providing proposals to the General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board, fees for the board members, any remuneration for committee work, proposal for and fees to the company’s auditor as well as principles for composition of the Nomination

    Orexo appoints Nomination Committee and publishes financial calendar 2017/2018

    Uppsala, Sweden – October 3, 2017 – Prior to the Annual General Meeting 2018, Orexo appoints a Nomination Committee which represents approximately 45 percent of the number of shares and votes in the company based on the last known shareholder information. The Nomination Committee, whose tasks include providing proposals to the General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board, fees for the board members, any remuneration for committee work, proposal for and fees to the company’s auditor as well as principles for composition of the Nomination

    Orexo appoints Nomination Committee and publishes financial calendar 2016/2017

    Uppsala, Sweden – September 29, 2016 – Prior to the Annual General Meeting 2017, Orexo appoints a Nomination Committee which represents approximately 45 percent of the number of shares and votes in the company based on the last known shareholder information. The Nomination Committee, whose tasks include providing proposals to the General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board, fees for the board members, any remuneration for committee work, proposal for and fees to the company’s auditor as well as principles for composition of the Nomination

    Orexo appoints Nomination Committee and publishes financial calendar 2015/2016

    Uppsala, Sweden – October 15, 2015 – Prior to the Annual General Meeting 2016, Orexo appoints a Nomination Committee which represents approximately 45 percent of the number of shares and votes in the company based on the last known shareholder information. The Nomination Committee, whose tasks include providing proposals to the General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board, fees for the board members, any remuneration for committee work, proposal for and fees to the company’s auditor as well as principles for composition of the Nomination

    Orexo appoints Nomination Committee and publishes financial calendar 2014/2015

    Prior to the Annual General Meeting 2015, Orexo appoints a Nomination Committee which represents approximately 45 percent of the number of shares and votes in the company based on the last known shareholder information. The Nomination Committee, whose tasks include providing proposals to the General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board, fees for the board members, any remuneration for committee work, proposal for and fees to the company’s auditor as well as principles for composition of the Nomination Committee, comprises: · Eivind Kolding,

    Orexo appoints Nomination Committee and publishes financial calendar 2013/2014

    Prior to the Annual General Meeting 2014, Orexo appoints a Nomination Committee which represents approximately 49 percent of the number of shares and votes in the company based on the last known shareholder information. The Nomination Committee, whose tasks include providing proposals to the General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board, fees for the board members, any remuneration for committee work, proposal for and fees to the company’s auditor as well as principles for composition of the Nomination Committee, comprises: • Ulrik Spork, Novo

    Orexo appoints Nomination Committee and publishes financial calendar 2012/2013

    Prior to the Annual General Meeting 2013, Orexo appoints a Nomination Committee which represents approximately 49 percent of the number of shares and votes in the company based on the last known shareholder information. The Nomination Committee, whose tasks include providing proposals to the General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board, fees for the board members, any remuneration for committee work, proposal for and fees to the company’s auditor as well as principles for composition of the Nomination Committee, comprises: · Ulrik Spork,

    Nomination Committee prior to Orexo’s Annual General Meeting 2012 and Financial calendar 2011/2012

    At Orexo’s Annual General Meeting on April 7, 2011, it was resolved that the company shall have a Nomination Committee consisting of one representative for each of the four largest shareholders, in terms of the number of votes, and the Chairman of the Board of Directors. The Nomination Committee, whose tasks include providing proposals to the General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board, fees for the board members, any remuneration for committee work, proposal for and fees to the company’s auditor as well as principles for composition of the

    Nomination Committee prior to Orexo’s Annual General Meeting 2011 and Financial calendar 2010/2011

    Pursuant to the decision at the 2010 Annual General Meeting, the composition of the Nomination Committee for the 2011 Annual General Meeting is hereby announced. At Orexo’s Annual General Meeting on April 21, 2010, it was resolved that the company shall have a Nomination Committee consisting of representatives for the largest shareholders in terms of the number of votes and the chairman of the Board of Directors. The Nomination Committee, whose tasks include providing proposals to the 2011 Annual General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board,

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media